While CHEK2 is considered a low-risk gene for CRC, we found previously reported truncating CHEK2 mutation p.R95* in a 52 year old woman diagnosed with MLH1/PMS2 deficient MSI-High CRC. The gene discussed is PMS2; the disease is colorectal carcinoma.